These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 19666693)
1. Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance? Eynon N; Meckel Y; Alves AJ; Yamin C; Sagiv M; Goldhammer E; Sagiv M Exp Physiol; 2009 Nov; 94(11):1147-52. PubMed ID: 19666693 [TBL] [Abstract][Full Text] [Related]
2. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Eynon N; Meckel Y; Sagiv M; Yamin C; Amir R; Sagiv M; Goldhammer E; Duarte JA; Oliveira J Scand J Med Sci Sports; 2010 Feb; 20(1):e145-50. PubMed ID: 19422653 [TBL] [Abstract][Full Text] [Related]
3. Genomic haplotype within the Peroxisome Proliferator-Activated Receptor Delta (PPARD) gene is associated with elite athletic status. Maciejewska-Karlowska A; Hanson ED; Sawczuk M; Cieszczyk P; Eynon N Scand J Med Sci Sports; 2014 Jun; 24(3):e148-55. PubMed ID: 24118591 [TBL] [Abstract][Full Text] [Related]
4. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385 [TBL] [Abstract][Full Text] [Related]
5. PPAR-α and PPARGC1A gene variants have strong effects on aerobic performance of Turkish elite endurance athletes. Tural E; Kara N; Agaoglu SA; Elbistan M; Tasmektepligil MY; Imamoglu O Mol Biol Rep; 2014 Sep; 41(9):5799-804. PubMed ID: 24996283 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis. Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258 [TBL] [Abstract][Full Text] [Related]
7. ACE I/D, ACTN3 R577X, PPARD T294C and PPARGC1A Gly482Ser polymorphisms and physical fitness in Taiwanese late adolescent girls. Chiu LL; Chen TW; Hsieh SS; Hsieh LL J Physiol Sci; 2012 Mar; 62(2):115-21. PubMed ID: 22247001 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial biogenesis related endurance genotype score and sports performance in athletes. Eynon N; Ruiz JR; Meckel Y; Morán M; Lucia A Mitochondrion; 2011 Jan; 11(1):64-9. PubMed ID: 20647061 [TBL] [Abstract][Full Text] [Related]
9. The PPARGC1A gene Gly482Ser in Polish and Russian athletes. Maciejewska A; Sawczuk M; Cieszczyk P; Mozhayskaya IA; Ahmetov II J Sports Sci; 2012; 30(1):101-13. PubMed ID: 22122487 [TBL] [Abstract][Full Text] [Related]
10. [Association of regulatory genes polymorphisms with aerobic and anaerobic performance of athletes]. Akhmetov II; Popov DV; Mozhaĭskaia IA; Missina SS; Astratenkova IV; Vinogradova OL; Rogozkin VA Ross Fiziol Zh Im I M Sechenova; 2007 Aug; 93(8):837-43. PubMed ID: 17926914 [TBL] [Abstract][Full Text] [Related]
11. Is there an association between PPARGC1A genotypes and endurance capacity in Chinese men? He Z; Hu Y; Feng L; Bao D; Wang L; Li Y; Wang J; Liu G; Xi Y; Wen L; Lucia A Scand J Med Sci Sports; 2008 Apr; 18(2):195-204. PubMed ID: 17490458 [TBL] [Abstract][Full Text] [Related]
12. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects. Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736 [TBL] [Abstract][Full Text] [Related]
13. [Association of PPARD gene polymorphism with human physical performance]. Akhmetov II; Astranenkova IV; Rogozkin VA Mol Biol (Mosk); 2007; 41(5):852-7. PubMed ID: 18240567 [TBL] [Abstract][Full Text] [Related]
15. The Hall ECR; Lockey SJ; Heffernan SM; Herbert AJ; Stebbings GK; Day SH; Collins M; Pitsiladis YP; Erskine RM; Williams AG J Sports Sci; 2023 Jan; 41(1):56-62. PubMed ID: 37012221 [TBL] [Abstract][Full Text] [Related]
16. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. Lucia A; Gómez-Gallego F; Barroso I; Rabadán M; Bandrés F; San Juan AF; Chicharro JL; Ekelund U; Brage S; Earnest CP; Wareham NJ; Franks PW J Appl Physiol (1985); 2005 Jul; 99(1):344-8. PubMed ID: 15705733 [TBL] [Abstract][Full Text] [Related]
17. The guanine nucleotide binding protein beta polypeptide 3 gene C825T polymorphism is associated with elite endurance athletes. Eynon N; Oliveira J; Meckel Y; Sagiv M; Yamin C; Sagiv M; Amir R; Duarte JA Exp Physiol; 2009 Mar; 94(3):344-9. PubMed ID: 19139061 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a 7-Gene Genetic Profile for Athletic Endurance Phenotype in Ironman Championship Triathletes. Grealy R; Herruer J; Smith CL; Hiller D; Haseler LJ; Griffiths LR PLoS One; 2015; 10(12):e0145171. PubMed ID: 26716680 [TBL] [Abstract][Full Text] [Related]
19. Is there an interaction between BDKRB2 -9/+9 and GNB3 C825T polymorphisms and elite athletic performance? Eynon N; Meckel Y; Alves AJ; Nemet D; Eliakim A Scand J Med Sci Sports; 2011 Dec; 21(6):e242-6. PubMed ID: 21210858 [TBL] [Abstract][Full Text] [Related]
20. Interaction between SNPs in the NRF2 gene and elite endurance performance. Eynon N; Alves AJ; Sagiv M; Yamin C; Sagiv M; Meckel Y Physiol Genomics; 2010 Mar; 41(1):78-81. PubMed ID: 20028934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]